Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual Kinase Targeting in Leukemia.
Mologni L, Marzaro G, Redaelli S, Zambon A. Mologni L, et al. Among authors: zambon a. Cancers (Basel). 2021 Jan 1;13(1):119. doi: 10.3390/cancers13010119. Cancers (Basel). 2021. PMID: 33401428 Free PMC article. Review.
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase.
Mologni L, Tardy S, Zambon A, Orsato A, Bisson WH, Ceccon M, Viltadi M, D'Attoma J, Pannilunghi S, Vece V, Bertho J, Goekjian P, Scapozza L, Gambacorti-Passerini C. Mologni L, et al. Among authors: zambon a. ACS Omega. 2022 May 11;7(20):17083-17097. doi: 10.1021/acsomega.2c00507. eCollection 2022 May 24. ACS Omega. 2022. PMID: 35647450 Free PMC article.
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase.
Mologni L, Orsato A, Zambon A, Tardy S, Bisson WH, Schneider C, Ceccon M, Viltadi M, D'Attoma J, Pannilunghi S, Vece V, Gueyrard D, Bertho J, Scapozza L, Goekjian P, Gambacorti-Passerini C. Mologni L, et al. Among authors: zambon a. Eur J Med Chem. 2022 Aug 5;238:114488. doi: 10.1016/j.ejmech.2022.114488. Epub 2022 May 25. Eur J Med Chem. 2022. PMID: 35665691
Correction to "Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase".
Mologni L, Tardy S, Zambon A, Orsato A, Schneider C, Bisson WH, Ceccon M, Viltadi M, Goyard D, Garcia P, D'Attoma J, Pannilunghi S, Vece V, Bertho J, Gueyrard D, Goekjian P, Scapozza L, Gambacorti-Passerini C. Mologni L, et al. Among authors: zambon a. ACS Omega. 2022 Jun 13;7(25):22059-22060. doi: 10.1021/acsomega.2c03469. eCollection 2022 Jun 28. ACS Omega. 2022. PMID: 35785321 Free PMC article.
Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
Puttini M, Redaelli S, Moretti L, Brussolo S, Gunby RH, Mologni L, Marchesi E, Cleris L, Donella-Deana A, Drueckes P, Sala E, Lucchini V, Kubbutat M, Formelli F, Zambon A, Scapozza L, Gambacorti-Passerini C. Puttini M, et al. Among authors: zambon a. Haematologica. 2008 May;93(5):653-61. doi: 10.3324/haematol.12212. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367480 Free article.
Cerium Containing Bioactive Glasses: A Review.
Zambon A, Malavasi G, Pallini A, Fraulini F, Lusvardi G. Zambon A, et al. ACS Biomater Sci Eng. 2021 Sep 13;7(9):4388-4401. doi: 10.1021/acsbiomaterials.1c00414. Epub 2021 Sep 1. ACS Biomater Sci Eng. 2021. PMID: 34468119 Free PMC article. Review.
Development and exploitation of CK2 inhibitors.
Sarno S, Ruzzene M, Frascella P, Pagano MA, Meggio F, Zambon A, Mazzorana M, Di Maira G, Lucchini V, Pinna LA. Sarno S, et al. Among authors: zambon a. Mol Cell Biochem. 2005 Jun;274(1-2):69-76. doi: 10.1007/s11010-005-3079-z. Mol Cell Biochem. 2005. PMID: 16335530
537 results